» Articles » PMID: 12961037

PET/CT: a New Imaging Technology in Nuclear Medicine

Overview
Date 2003 Sep 10
PMID 12961037
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

This review discusses the technical background of combined PET and CT and considers the clinical applications of PET/CT imaging. Questions addressed include: Is PET/CT superior to PET imaging alone? If so, in which patient populations and in what respect? Can PET/CT imaging affect patient management? Can PET/CT be practiced economically? While much work remains to be done, the available data clearly suggest that PET/CT decreases imaging time per patient and, even for the experienced reader, significantly reduces the number of equivocal PET interpretations. PET/CT also has the ability to improve accuracy of PET image interpretation and to affect clinical decision making, thereby improving patient management. The nuclear medicine community should approach this new technology with an open mind and focus on its clinical usefulness. The decision regarding whether PET/CT should be part of the equipment in a given nuclear medicine or radiology practice largely depends on the specific patient population. It is concluded that present skepticism concerning combined PET/CT will subside once critics of this new modality have had the opportunity to clearly see on images its many advantages compared with either PET alone or conventional image fusion approaches.

Citing Articles

Assessment of radiation knowledge among medical personnel in nuclear emergency preparedness: a cross-sectional study.

Xie Y, Wang X, Lan Y, Xu X, Shi S, Yang Z Front Public Health. 2025; 13:1547818.

PMID: 40078773 PMC: 11899641. DOI: 10.3389/fpubh.2025.1547818.


Optimizing Low-Dose [18F]FDG-PET/CT Scans: Ensuring Quality Amid Radiotracer Availability Challenges - Insights from a Peripheral Tertiary Care Center.

Tayal S, Jain Y, Thakur S, Shukla V, Venkatachalam M, Kumar A Indian J Nucl Med. 2025; 39(4):292-298.

PMID: 39790828 PMC: 11708796. DOI: 10.4103/ijnm.ijnm_90_24.


Endocrinology application of molecular imaging: current role of PET/CT.

Calderoni L, Giovanella L, Fanti S J Endocrinol Invest. 2024; 47(10):2383-2396.

PMID: 38837101 PMC: 11393017. DOI: 10.1007/s40618-024-02400-8.


Recent Developments in Porous Silicon Nanovectors with Various Imaging Modalities in the Framework of Theranostics.

Qian J, Wen H, Tamarov K, Xu W, Lehto V ChemMedChem. 2022; 17(10):e202200004.

PMID: 35212460 PMC: 9314675. DOI: 10.1002/cmdc.202200004.


Habitat Imaging-Based F-FDG PET/CT Radiomics for the Preoperative Discrimination of Non-small Cell Lung Cancer and Benign Inflammatory Diseases.

Chen L, Liu K, Zhao X, Shen H, Zhao K, Zhu W Front Oncol. 2021; 11:759897.

PMID: 34692548 PMC: 8526895. DOI: 10.3389/fonc.2021.759897.


References
1.
Kluetz P, Meltzer C, Villemagne V, Kinahan P, Chander S, Martinelli M . Combined PET/CT Imaging in Oncology. Impact on Patient Management. Clin Positron Imaging. 2001; 3(6):223-230. DOI: 10.1016/s1095-0397(01)00055-3. View

2.
Delbeke D . Oncological applications of FDG PET imaging. J Nucl Med. 1999; 40(10):1706-15. View

3.
Votaw J, White M . Comparison of 2-dimensional and 3-dimensional cardiac 82Rb PET studies. J Nucl Med. 2001; 42(5):701-6. View

4.
Burger C, Goerres G, Schoenes S, Buck A, Lonn A, von Schulthess G . PET attenuation coefficients from CT images: experimental evaluation of the transformation of CT into PET 511-keV attenuation coefficients. Eur J Nucl Med Mol Imaging. 2002; 29(7):922-7. DOI: 10.1007/s00259-002-0796-3. View

5.
Mac Manus M, Wong K, Hicks R, Matthews J, Wirth A, Ball D . Early mortality after radical radiotherapy for non-small-cell lung cancer: comparison of PET-staged and conventionally staged cohorts treated at a large tertiary referral center. Int J Radiat Oncol Biol Phys. 2002; 52(2):351-61. DOI: 10.1016/s0360-3016(01)02673-6. View